Asthma Severity, Psychiatric Morbidity, and Quality of Life: Correlation with Inhaled Corticosteroid Dose

References

• Beasley R, Crane J, Lai CKW, Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol 2000; 105: S466–S472
   PubMed Web of Science ®Google Scholar
• American Academy of Allergy, Asthma and Immunology. Overview of Allergic Diseases. the American Academy of Allergy, Asthma and Immunology, Inc, Milwaukee, WI 2000; Vol 1, The Allergy Report
   Google Scholar
• Asthma in America Survey Project. Schulman, Ronca & Bucuvalas, Inc., Washington, DC 20036 1996, 1901 L Street NW. Suite 300
   Google Scholar
• McDaniel JS. Psychological factors affecting medical conditions. Text Book of Psychiatry. II ed. 565–585
   Google Scholar
• Sharma S, Nanda Kumar VK. Some psychological concomitants of bronchial asthma. J Assoc Physicians India 1981 M ay; 29(5)373
   Google Scholar
• Bousquet J, Knani J, Dhivert H, Richard A, Chicaye A, Ware JE., Jr, Michel FB. Quality of life in asthma: 1. Internal consistency and validity of the SF-36 Questionnaire. Am J Respir Crit Care Med 1994; 149: 371–375
   PubMed Web of Science ®Google Scholar
• Schipper H, Clinch J, Powell V. Definitions and conceptual issues. Quality of Life and Pharmacoeconomics in Clinical Trials, B. Spilker. Lippincott-Raven Publishers, Philadelphia 1996; 11–23
   Google Scholar
• Juniper EF. Effect of asthma on quality of life. Can Respir J 1998; 5(Suppl A)77A–84A
   Google Scholar
• Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet LP, Haukioja A. Quality of life in asthma clinical trials: Comparison salmeterol and salbutamol. Am J Respir Crit Care Med 1995; 151(1)66–70
   Google Scholar
• Rutten-van Molken MP, Custers F, van Doorslaer EK, Jansen C, Heurman L, Maesen FP, Smerts JJ, Bommer AM, Raagimakers JA. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995; 8(6)885–887
   Google Scholar
• Rowe RH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respir Dis 1993; 148: 675–681
   PubMed Web of Science ®Google Scholar
• Leidy NK, Coughlin C. Psychometric performance of the asthma quality of life questionnaire in a US sample. Qual life Res 1998; 7: 127–134
   PubMed Web of Science ®Google Scholar
• Juniper EF, Svensson K, O'Byrne PM, Barnes PJ, Bauer CA, Lofdahl CG, Postma DS, Pauwels RA, Tattersfield AE, Ullman A. Asthma quality of life during 1 year treatment with budesonide with or without formeterol. Eur Respir J 1999; 14: 1038–1043
   PubMed Web of Science ®Google Scholar
• van Schayck CP, Dompeling E, Rutten MP, Folgering H, van den Boom G, van Weel C. The influence of an inhaled steroid on quality of life in patients with asthma or COPD. Chest 1995; 107: 1199–1205
   PubMed Web of Science ®Google Scholar
• Brown ES, Khan DA, Nejtek VA. The psychiatric side effects of corticosteroids. Ann Allergy Asthma Immunol 1999; 83: 495–504
   PubMed Web of Science ®Google Scholar
• Dluhy RG. Clinical relevance of inhaled cortico steroids and HPA axis suppression. J Allergy Clin Immunol 1998; 101: S447–S450
   Google Scholar
• Brown PH, Blundell G, Greening AP, Crompton GK. Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids. Respir Med 1991; 85: 501–510
   PubMed Web of Science ®Google Scholar
• Van Schoor J, Toogood JH, Pauwels RA. Short courses of high dose inhaled budesonide and serum IgG subclasses in healthy volunteers. J Allergy Clin Immunol 1996; 97: 113–118
   Google Scholar
• Faul JL, Tormey W, Tormey V, Burke C. High dose inhaled corticosteroids and dose dependent loss of diabetic control. BMJ Nov 28, 1998; 317(7171)1491
   PubMedGoogle Scholar
• Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Eng J Med 2000; 343: 1064–1069
   PubMed Web of Science ®Google Scholar
• Cumming RG, Mitchell P, Leeder SR. Use of inhaled coticosteroids and the risk of cataracts. N Engl J Med 1997; 337: 8–14
   PubMed Web of Science ®Google Scholar
• Toogood JH, Markov AE, Baskerville J, Dayson C. Association of ocular cataracts with inhaled corticosteroid therapy during long-term treatment of asthma. J Allergy Clin Immunol 1993; 91: 571–579
   PubMed Web of Science ®Google Scholar
• Wong CA, Walsh LJ, Smith CJ, Wisniewski AF, Lewis SA, Hubbard R, Cawte S, Green DJ, Pringle M, Tattersfield AE. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 2000; 355: 1399–1403
   PubMed Web of Science ®Google Scholar
• Bonala SB, Reddy BM, Silverman BA, Bassett CW, Rao YA, Amara S, Schneider AT. Bone mineral density in women with asthma on long-term inhaled corticosteroid therapy. Ann Allergy Asthma Immunol 2000; 85: 495–500
   Google Scholar
• Ling MH, Perry PJ, Tsuang MT. Side of effects of corticosteroid therapy psychiatric aspects. Arch Gen Psychiatry 1981 A pr; 38(4)471–477
   Google Scholar
• Lewis DA, Smith RE. Steroid-induced psychiatric syndomes. A report of 14 cases and a review of literature. J Affect Disord Nov, 1983; 5(4)319–332
   PubMed Web of Science ®Google Scholar
• Vanelle JM, Aubin F, Michel F. Psychiatric complications of corticotherapy. Rev Prat Feb 21, 1990; 40(6)556–558
   Google Scholar
• Reckart MD, Eisendrath SJ. Exogenous corticosteroid effects on mood and cognition: case presentations. Int J Psychosom 1990; 37(1–4)57–61
   PubMedGoogle Scholar
• Brown ES, Suppes T. Mood symptoms during corticosteroids therapy: a review. Harv Rev Psychiarty Jan-Feb, 1998; 5(5)239–246
   Web of Science ®Google Scholar
• Dawson KL, Carter ER. A steroid-induced acute psychosis in a child with asthma. Pediatric Pulmonology 1998; 26(5)362–364
   Google Scholar
• Patten SB, Neutel CI. Corticosteroid-induced adverse psychiatric effects. Drug Safety Feb, 2000; 22(2)111–122
   PubMedGoogle Scholar
• Wada K, Yamada N, Suzuki H, Lee Y, Kuroda S. Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment. J Clin Psychiatry 2000; 61: 261–267
   Google Scholar
• Patten SB, William JV, Love EJ. A case controlled study of corticosteroid exposure as a risk factor for clinically-diagnosed depressive disorders in a hospitalized population. Can J Psychiatry Sep, 1995; 40(7)396–400
   Google Scholar
• The Boston Collaborative Drug Surveillance Program Boston, Mass. Boston University Medical Center. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972; 13: 694–698
   Google Scholar
• Smyllie H, Connolly C. Incidence of serious complications of corticosteroid therapy in respiratory disease. Thorax 1968; 23: 571–581
   PubMed Web of Science ®Google Scholar
• O'Byrne PM, Pendersen S. Measuring efficacy and safety of different inhaled corticosteroid preparations. J Allergy Clin Immunol 1998; 102: 879–886
   PubMed Web of Science ®Google Scholar
• Boushey H. Effects of inhaled corticosteroids on the consequences of asthma. J Allergy Clin Immunol 1998; 102: S5–S16
   PubMed Web of Science ®Google Scholar
• Expert Panel Report 2 1997, Guidelines for the Diagnosis and Management of Asthma. National Institute of Health publication
   Google Scholar
• Toogood JH. Side effects of inhaled corticosteroids. J Allergy Clin Immunol 1998; 102: 705–713
   PubMed Web of Science ®Google Scholar
• Lewis LD, Cochrane GM. Psychosis in child inhaling budesonide. Lancet 1983; ii: 634
   Google Scholar
• Meyboom R. Budesonide and psychotic side effects. Ann Int Med 1988; 109: 683
   Web of Science ®Google Scholar
• Phelan MC. Beclomethasone mania. Brit J Psychiatry 1989; 155: 871–872
   Google Scholar
• Connet G, Lenney W. Inhaled budesonide and behavioral disturbances. Lancet 1991; 338: 634–635
   Google Scholar
• Goldstein ET, Preskorn SH. Mania triggered by a steroid nasal spray in a patient with stable bipolar disorder. Am J Psychiatry 1989; 146(8)1076
   Google Scholar
• Anderson RT, Aaronson NK, Bullinger M, McBee WlL. A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research. Pharmacoeconomics Oct, 1996; 10(4)336–355
   PubMed Web of Science ®Google Scholar
• Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the asthma quality of life questionnaire. Chest 1999; 115: 1265–1270
   PubMed Web of Science ®Google Scholar
• n = z2pq/d2. Determination of sample size for estimating proportions. Biostatistics: A Foundation for the Analysis in the Health Sciences. 5th ed., F. Daniel. Wiley & Sons. 154–157
   Google Scholar
• Tohen M, Bromet E, Murphy JM, Tsuang MT. Psychiatric Epidemiology. Harvard Rev Psychiatry Sep, 2000; 8(3)111–125
   Google Scholar